1783P PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase

Annals of Oncology(2023)

引用 0|浏览4
暂无评分
关键词
androgen deprivation therapy,prostate cancer,ipilimumab-nivolumab,ipi-nivo,high-volume,hormone-sensitive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要